DAX24.915 -0,3%Est506.284 +0,3%MSCI World4.343 -0,1%Top 10 Crypto8,2400 -1,0%Nas25.915 -1,4%Bitcoin56.014 -0,8%Euro1,1438 -0,2%Öl84,19 -0,9%Gold3.983 -1,9%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
SpaceX A42D4F Rheinmetall 703000 Infineon 623100 NVIDIA 918422 Siemens Energy ENER6Y SAP 716460 PayPal A14R7U Micron Technology 869020 Deutsche Telekom 555750 Volkswagen (VW) vz. 766403 BYD A0M4W9 Microsoft 870747 Lufthansa 823212 Apple 865985 Novo Nordisk A3EU6F
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Iran-Konflikt: DAX letztlich tiefer -- Wall Street rot -- Uber übernimmt Delivery Hero -- ASML, VW, IBM, Infineon, Rüstungsaktien, NVIDIA, EVOTEC, BYD, TSMC, Samsung, SK hynix im Fokus
Top News
Aktueller Marktbericht zum Goldpreis, Ölpreis, Silberpreis und Erdgaspreis Aktueller Marktbericht zum Goldpreis, Ölpreis, Silberpreis und Erdgaspreis
Auf Micron, AMD & Co. folgend: Aktien von SK hynix und Samsung brechen nach Kurssprung ein Auf Micron, AMD & Co. folgend: Aktien von SK hynix und Samsung brechen nach Kurssprung ein
Suche...
Jetzt kostenlos
bei finanzen.net anmelden
Watchlists & Musterdepots Tools & integriertes Trading Newsletter, Trading-Desk uvm.
Schon einen Account? Anmelden
Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

United Community Banks Aktie

Kaufen
Verkaufen
31,20 EUR +0,20 EUR +0,65 %
FSE
37,09 USD +1,12 USD +3,11 %
BTT
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.3,72 Mrd. EUR

KGV11,92Div. Rendite3,14%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA1JB5Q

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS90984P3038

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolUCB

United Community Banks Aktien News

DatumMeistgelesen
PR NewswireUCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduced countable motor seizure frequency in CDKL5 deficiency disorder
PR NewswireUCB shares leading scientific research and advances at American Epilepsy Society Annual Meeting
PR NewswireUnited Community Climbs 32 Spots on American Banker's 2025 Best Banks to Work For List
PR Newswire/C O R R E C T I O N -- UCB/
PR NewswireU.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)
PR NewswireUCB opens applications for 2026 UCB Myasthenia Gravis Scholarship™
PR NewswireUCB to unveil new data for RYSTIGGO® (rozanolixizumab-noli) and ZILBRYSQ®(zilucoplan) for gMG at the 2025 AANEM Annual Meeting and MGFA Scientific Session
PR NewswireBIMZELX® (bimekizumab-bkzx) Three-Year Rheumatology Data at ACR 2025 Demonstrated Sustained Inflammation Control in Psoriatic Arthritis and Axial Spondyloarthritis
PR NewswireResults published in Neurology highlight a 95% reduction in risk of death with pyrimidine nucleos(t)ide therapy in patients with thymidine kinase 2 deficiency (TK2d)
PR NewswireBIMZELX® (bimekizumab-bkzx) Data in Moderate-to-Severe Plaque Psoriasis at EADV Showed Complete Skin Clearance Sustained Over Four Years
PR NewswireBIMZELX® (bimekizumab-bkzx) New Three-year Data in Hidradenitis Suppurativa at EADV Showed Sustained Symptom Relief Across Multiple Clinical Endpoints
PR NewswireGen Z and Millennial Patients with Chronic Rheumatic Diseases Are Opening Up to Raise Awareness for Improved Care
PR NewswireUCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress
PR NewswireUCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress
PR NewswireUCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress
PR NewswireUCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress
PR NewswireUCB's HS Summit United Patients and Experts to Drive Progress in Hidradenitis Suppurativa Awareness and Treatment
PR NewswireUCB extends its BIMZELX® "Get Yourself Back" direct-to-consumer campaign for the hidradenitis suppurativa community
PR NewswireUCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder
PR NewswireUCB presents latest thymidine kinase 2 deficiency (TK2d) research at the United Mitochondrial Disease Foundation (UMDF) 2025 Conference
PR NewswireInaugural 2025 UCB U.S. Myasthenia Gravis Scholarship™ grants 15 scholarships to people impacted by myasthenia gravis in the U.S.
PR NewswireUCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity
PR NewswireBIMZELX® (bimekizumab-bkzx) Three-Year Data at EULAR 2025 Showed Lasting Efficacy and Control of Inflammation in Psoriatic Arthritis and Axial Spondyloarthritis
PR NewswireUCB and Domino Data Lab Collaborate to Modernize Statistical Computing Environment in Life Sciences
PR NewswireUCB presents latest research across leading neurology portfolio at American Academy of Neurology (AAN) meeting 2025
PR NewswireUnited Community earns 11th J.D. Power Award in the last 16 years, Ranking #1 for Retail Banking Customer Satisfaction in the Southeast, plus #1 in Trust and People
PR NewswireNew data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference
PR NewswireEpilepsia Publishes Final Analysis of Open-Label Extension Study of Long-Term Safety and Effectiveness of FINTEPLA® (fenfluramine) in Children and Adults with Dravet Syndrome
PR NewswireBIMZELX® (bimekizumab-bkzx) Five-Year Data at AAD 2025 Showed Sustained Skin Clearance and Long-Term Efficacy in Moderate-to-Severe Plaque Psoriasis
PR NewswireBIMZELX® (bimekizumab-bkzx) Two-Year Data at AAD Showed Potential to Eliminate Draining Tunnels in Hidradenitis Suppurativa, and Reduction in Disease Burden
PR NewswireOn Growth Path for a Decade plus: Strong Launch Execution driving Company Growth
PR NewswireUnited Community earns Coalition Greenwich Best Bank awards for Middle Market and Small Business Banking
PR NewswireUCB Announces U.S. Availability of 320 mg/2 mL Single-Injection Administration Option for BIMZELX® (bimekizumab-bkzx)
PR NewswireUCB Presents New Data on Impact and Burden of Epilepsy at 2024 American Epilepsy Society (AES) Annual Meeting
PR NewswireUCB presents latest scientific research in epilepsy at American Epilepsy Society (AES) Annual Meeting
PR NewswireUCB Receives U.S. FDA Approval for BIMZELX® (bimekizumab-bkzx) as the First IL-17A and IL-17F Inhibitor for Adults with Moderate-to-Severe Hidradenitis Suppurativa
PR NewswireNew BIMZELX® (bimekizumab-bkzx) Data at ACR Convergence 2024 Highlights UCB's Efforts to Deliver Differentiated Care for Patients with Psoriatic Arthritis and Axial Spondyloarthritis
PR NewswireUnited Community earns 8th consecutive recognition as one of the Best Banks to Work For
PR NewswireUCB showcases new data for gMG management at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting and Myasthenia Gravis Foundation of America (MGFA) S...
PR NewswireUnited Community Bank Foundation Pledges $350,000 to Hurricane Relief Efforts in Western North Carolina

United Community Banks News

United Community Banks News: auf dieser Seite finden Sie alle United Community Banks News und Nachrichten zur United Community Banks Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch United Community Banks News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um United Community Banks News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.